Results

eNauka >  Results >  Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study
Title: Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study
Authors Wray, Sibyl; ...; Drulović, Jelena S. ; ...; (broj koautora 17)
Issue Date: 2022
Publication: Advances in therapy
ISSN: 0741-238X Advances in Therapy Search Idenfier
Publisher: New York : Springer Healthcare Communications
Type: Article
Collation: vol. 39 br. 4 str. 1810-1831
DOI: 10.1007/s12325-022-02068-7
WoS-ID: 000761885100001
Scopus-ID: 2-s2.0-85125142028
PMID: 35211872
PMCID: PMC8870078
URI: https://enauka.gov.rs/handle/123456789/819500
URL: https://link.springer.com/article/10.1007/s12325-022-02068-7
Project: Biogen (Cambridge, MA, USA)
Biogen
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21M21

29
SCOPUSTM
17
PubMed CentralTM
4
OpenCitations
29
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.